ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study